Trans Tasman Radiation Oncology Group (TROG)

Trans Tasman放射肿瘤学小组是一个经验丰富的研究小组，开展包括放射治疗（RT）在内的癌症临床试验，以提高治愈率、生活质量和减少治疗的副作用。50%的癌症患者需要RT作为治疗的一部分。该建议的目的是通过(a)通过电子手段快速审查和检查治疗，以及(b)改进试验设计，加强RT试验的质量和安全性。

The Trans Tasman Radiation Oncology Group is an experienced research group conducting cancer clinical trials involving radiotherapy (RT) in order to improve cure rates, quality of life and to reduce side-effects of treatment. Fifty per cent of all cancer patients need RT as part of their treatment. The aim of the proposal is to strengthen the quality and safety of RT trials by (a) enabling rapid review and checking of treatment by electronic means and (b) improve trial design.